Improvement In Fibroid Symptoms Shown With Longer Ultrasound Treatment
This article was originally published in The Gray Sheet
Executive Summary
Uterine fibroid sufferers who received three hours of treatment via magnetic resonance-guided, focused ultrasound surgery (MRgFUS) enjoyed greater symptom relief after a year than those treated for the two hours specified in the original FDA-approved protocol, a postapproval study of 160 women found
You may also be interested in...
Evidence On Uterine Fibroid Treatments “Weak,” AHRQ Says
The evidence on the effectiveness of various device-related treatments to shrink uterine fibroids or minimize their symptoms is still too weak to make meaningful comparisons between them, the Agency for Healthcare Research and Quality says in a 1review of over 100 studies on the topic
Evidence On Uterine Fibroid Treatments “Weak,” AHRQ Says
The evidence on the effectiveness of various device-related treatments to shrink uterine fibroids or minimize their symptoms is still too weak to make meaningful comparisons between them, the Agency for Healthcare Research and Quality says in a 1review of over 100 studies on the topic
For InSightec, CMS Holds Ticket To Treating Fibroids In Younger Women
The lack of third-party reimbursement has hindered sales of InSightec's ExAblate 2000 uterine fibroid treatment, but the firm is hopeful that recent recommendations from CMS' advisory panel for hospital outpatient payments will help the unique treatment gain traction